Original Article
Nicholas J. Newman, PharmD; Sara E. Gordon, PharmD, BCOP; Charles J. Nock, MD; Christopher J. Burant, PhD; Candice M. Wenzell, PharmD, BCOP
Jessica Marini, PharmD, BCOP; Bailey Bass Hammond, PharmD; Jacob Rennebaum, PharmD;
Erin Weeda, PharmD, BCPS; Jagoda Misniakiewicz, PharmD; Amy Sion, PharmD, BCOP
Emily H. Hsu, PharmD, and Ryan Beechinor, PharmD, BCPS, BCOP
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma
Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA
Jacqueline Saunders, PharmD, BCPS; Sumati Murli, PhD; Michelle A. Rudek, PharmD, PhD;
Anand Khandoobhai, PharmD, MS; Anne DeLisa, PharmD, CCRP; Amy Goodrich, RN, MSN, CRNP-AC;
Janet Mighty, BS Pharm, MBA
Trace Bartels, PharmD; Molly Klanderman, PhD, MS; Jaime Rogers, MSN, RN; Kristin Gray, MSN, RN; Heidi Kosiorek, MS; Chris Coughlin, PharmD, BCOP
Brianna Archambeau, PharmD, BCOP; Ashley M. Leece, PharmD, BCOP, BCPS; Dhaval Patel, PharmD, BCOP; Chin Y. Liu, MS, PharmD, BCOP
Christopher Sinoimeri, PharmD; Bryan Do, PharmD, BCOP; Sheree Chen, PharmD, BCOP
Donyika Joseph, PharmD, BCOP; Farnaz Foolad, PharmD, BCPS; Neelam K. Patel, PharmD, BCOP;
Meghan Karuturi, MD, MSc; Jaime Kaushik, PharmD, BCOP
Esra Nusseibeh, PharmD; Lynn Weber, PharmD, BCOP; Katie Won, PharmD, BCOP;
Shannon Reidt, PharmD, MPH